-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Stomach cancer (GC) is one of the most common types of cancer and the third most common cause of cancer worldwide.
cisplatin is a drug used in cancer treatment.
the use of cisplatin in patients remains a concern due to chemotherapy resistance and some potential adverse effects.
addition, many anti-cancer drugs with toxic side effects also kill normal cells, so herbs may be an effective strategy to reduce anti-cancer side effects.
researchers have found that natural compounds extracted from plants and animals may be a new treatment strategy for cancer treatment.
previous studies have found a powerful herbal formula called SH003, with a ratio of 1:1:1 (w/w) jaundice (Am), Ag andfloor (Tk), as herbs with anti-cancer effects such as anti-inflammatory, anti-angiogenesic and anti-tumor effects.
study found that SH003, a herbal preparation, can induce endosurance network (ER) stress by mediating the PERK-ATF4-CHOP signal transducting path.
SH003-mediated endosinonet stress response inhibits G9a (a histone methyl transferase) and activates cell autophagy by reducing the phosphorylation level of STAT3, which starts with the dissociation of Beclin-1 and the Bcl-2/Beclin-1 complex.
expression of PERK and CHOP can inhibit SH003-induced cell death and autophagy activation.
addition, the use of LC3B or p62-specific siRNA or autophagy inhibitor 3-MA to target cell autophagy can also effectively inhibit SH003 induced GC cell death.
interesting is that SH003 in GC is able to induce BNIP3-mediated autophagy cell death under oxygen-deprived and very oxygen-deprived conditions.
addition, these results show that in hypoxia, SH003-induced endocystic network stress response can regulate the autophagy cell death process induced by BNIP3 by inhibiting the STAT3-G9a path pathline.
, SH003 therapy may be an important cancer treatment strategy under hypoxia-mediated chemotherapy resistance.
.